[1]
Bancu, A. et al. 2021. PD-L1 testing and immunotherapy selection – early laboratory experience and its potential role in head and neck cancer management. Archive of Clinical Cases. 8, 1 (Jun. 2021), Arch Clin Cases 2021; 8(1):14–18. DOI:https://doi.org/10.22551/2021.30.0801.10179.